Choate Investment Advisors Amgen Inc Transaction History

Choate Investment Advisors

$3.89 Billion
Q3 2024

A detailed history of Choate Investment Advisors transactions in Amgen Inc stock. As of the latest transaction made, Choate Investment Advisors holds 17,569 shares of AMGN stock, worth $4.92 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

17,569

Previous 17,924 1.98%

Holding current value

$4.92 Million

Previous $5.6 Million 1.07%

% of portfolio

0.15%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $109,829 - $119,769	-355 Reduced 1.98%	17,569 $5.66 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $16,290 - $19,797	-62 Reduced 0.34%	17,924 $5.6 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $268,332 - $323,910	-998 Reduced 5.26%	17,986 $5.11 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $250,586 - $282,690	980 Added 5.44%	18,984 $5.47 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $88,115 - $109,398	403 Added 2.29%	18,004 $4.84 Million
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $757,872 - $896,169	3,537 Added 25.15%	17,601 $3.91 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $8,805 - $10,732	-39 Reduced 0.28%	14,064 $3.4 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $20,154 - $25,608	88 Added 0.63%	14,103 $3.7 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $33,893 - $38,225	-151 Reduced 1.07%	14,015 $3.16 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $139,810 - $155,584	-606 Reduced 4.1%	14,166 $3.45 Million
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $61,395 - $67,919	-280 Reduced 1.86%	14,772 $3.57 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $182,174 - $208,481	-916 Reduced 5.74%	15,052 $3.39 Million
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $140,310 - $164,390	-661 Reduced 3.97%	15,968 $3.4 Million
Q2 2021 Jul 30, 2021	SELL	$233.58 - $259.14 $227,506 - $252,402	-974 Reduced 5.53%	16,629 $4.05 Million
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $28,182 - $32,842	127 Added 0.73%	17,603 $4.38 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $18,392 - $21,901	-85 Reduced 0.48%	17,476 $4.02 Million
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $61,478 - $68,368	-262 Reduced 1.47%	17,561 $4.46 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $52,419 - $64,326	-265 Reduced 1.47%	17,823 $4.2 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $168,754 - $223,814	-926 Reduced 4.87%	18,088 $3.67 Million
Q4 2019 Jan 28, 2020	BUY	$189.21 - $243.2 $378 - $486	2 Added 0.01%	19,014 $4.58 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $132,497 - $158,759	-761 Reduced 3.85%	19,012 $3.68 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $1,667 - $1,954	-10 Reduced 0.05%	19,773 $3.64 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $493,051 - $555,776	-2,726 Reduced 12.11%	19,783 $3.76 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $175,902 - $205,334	-986 Reduced 4.2%	22,509 $4.38 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $52,992 - $59,742	286 Added 1.23%	23,495 $4.87 Million
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $131,843 - $148,088	-794 Reduced 3.31%	23,209 $4.28 Million
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $44,560 - $52,074	-263 Reduced 1.08%	24,003 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $33,420 - $37,340	198 Added 0.82%	24,266 $0
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $4.03 Million - $4.6 Million	24,068	24,068 $0

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Choate Investment Advisors with notifications on news.

Account

Choate Investment Advisors Amgen Inc Transaction History